Bandi e contributi per enti del terzo settore

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Stati Uniti · US

Chi può richiederla Special district governments · City or township governments · Independent school districts · Public housing authorities/Indian housing authorities · For profit organizations other than small businesses · Native American tribal organizations (other than Federally recognized tribal governments) · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Small businesses · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · County governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · State governments · Public and State controlled institutions of higher education · Native American tribal governments (Federally recognized)

This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network (BPN) or other translational programs.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

Stati Uniti · US

Chi può richiederla Small businesses · For profit organizations other than small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · State governments · City or township governments · Native American tribal organizations (other than Federally recognized tribal governments) · Public housing authorities/Indian housing authorities · County governments · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Special district governments · Public and State controlled institutions of higher education · Native American tribal governments (Federally recognized)

This funding opportunity announcement (FOA) encourages the development and validation of animal models and human/animal tissue ex vivo systems that recapitulate the phenotypic and physiologic characteristics of a defined neurological or neuromuscular disorder. The goal of this FOA is to promote a significant improvement in the translational relevance of animal models or ex vivo systems that will be utilized to facilitate future development of neurotherapeutics. Ideally, models proposed for this FOA would have the potential to provide feasible and meaningful assessments of efficacy following therapeutic intervention that would be applicable in both preclinical and clinical settings. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Program focused on enabling the exploratory and early stages of drug discovery.

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

Stati Uniti · US

Chi può richiederla Private institutions of higher education · Public and State controlled institutions of higher education

The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for health professional, undergraduate and graduate students and enhancing the research environment at applicant institutions.Eligible institutions must award baccalaureate or advanced science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F&A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the schools and colleges within the institution as a whole.Help determining the Organization Funding Level can be found here or https://grants.nih.gov/grants/funding/r15.htmThis REAP Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For purposes of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

Stati Uniti · US

Chi può richiederla Public and State controlled institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Native American tribal governments (Federally recognized) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · County governments · Public housing authorities/Indian housing authorities · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Private institutions of higher education · Special district governments · State governments · Small businesses · City or township governments

Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This FOA supports a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often long-term approach. Projects seeking support for a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies should consider the companion U01 FOA.

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

Stati Uniti · US

Chi può richiederla Public housing authorities/Indian housing authorities · Native American tribal organizations (other than Federally recognized tribal governments) · For profit organizations other than small businesses · Special district governments · Small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · City or township governments · County governments · State governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized) · Private institutions of higher education · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education

Reissue of PAR-20-118. This Notice of Funding Opportunity (NOFO) encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This NOFO using the U01 mechanism supports a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies Projects seeking support for a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often long-term approach should consider the companion U19 FOA.

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Stati Uniti · US

Chi può richiederla Others (see text field entitled "Additional Information on Eligibility" for clarification) · Independent school districts · State governments · Private institutions of higher education · Public and State controlled institutions of higher education · City or township governments · Special district governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Public housing authorities/Indian housing authorities · For profit organizations other than small businesses · County governments · Native American tribal governments (Federally recognized) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses

The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility and thus saving NCI time and money.

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Stati Uniti · US

Chi può richiederla Small businesses · Independent school districts · Native American tribal governments (Federally recognized) · Private institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · County governments · Native American tribal organizations (other than Federally recognized tribal governments) · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · State governments · For profit organizations other than small businesses · Public housing authorities/Indian housing authorities · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public and State controlled institutions of higher education

The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility and thus saving NCI time and money.

bases que rexerán o procedemento de concesión de axudas a entidades privadas para o fomento da gratuidade da atención educativa dos nenos e nenas da Comunidade Autónoma de Galicia en escolas infantís 0-3 para o curso 2026/2027 e se procede á súa convocato

AUTONOMICA - GALICIA - CONSELLERÍA DE POLÍTICA SOCIAL E IGUALDAD ·

Educación

Periodo: 28/7/2026 – —

Etichettare i progetti che possono beneficiare del FESR nell'ambito del sostegno alla biodiversità e alla lotta contro le inondazioni nel bacino della Senna

Francia · FR

Chi può richiederla Commune · Intercommunalité / Pays · Département · Etablissement public dont services de l'Etat · Entreprise publique locale (Sem, Spl, SemOp)

Il presente bando a progetti, lanciato dalla Direzione regionale e interdipartimentale dell'ambiente, della pianificazione e dei trasporti (DRIEAT), mira a etichettare i progetti che possono beneficiare del FESR nell'ambito del sostegno alla biodiversità e della lotta contro le inondazioni nel bacino della Senna, nell'ambito del Programma regionale 2021-2027. La dotazione dedicata al tema delle continuità ecologiche è di 3,5 milioni di euro. GLI OBIETTIVI DEL BANDO A PROGETTI Il presente bando a progetti mira a stimolare e preselezionare operazioni che contribuiscono al ripristino della continuità ecologica dei corsi d'acqua al fine di riconquistare gli assi migratori. Le operazioni corrisponderanno ai seguenti obiettivi: Migliorare la continuità dei corsi d'acqua per consentire ai pesci migratori di ampliare la loro area di distribuzione Garantire il monitoraggio delle popolazioni e lo sviluppo delle conoscenze sulle diverse specie Ripristinare le popolazioni di pesci migratori anfiialini del bacino della Senna e delle coste normanne

Periodo: 5/6/2024 – —

Etichettare i progetti che possono beneficiare del FESR a titolo di sostegno alla biodiversità e alla lotta contro le inondazioni nel bacino della Senna

Francia · FR

Chi può richiederla Commune · Département · Etablissement public dont services de l'Etat

Il presente bando a progetti, lanciato dalla DRIEAT, mira a etichettare i progetti che possono beneficiare del FESR a titolo di sostegno alla biodiversità e alla lotta contro le inondazioni nel bacino della Senna, nell'ambito del Programma regionale 2021-2027. L'importo destinato alle inondazioni è di 5,5 milioni di euro. GLI OBIETTIVI DEL BANDO A PROGETTI Il presente bando a progetti mira a promuovere e preselezionare operazioni che rispondano ad almeno uno dei 3 grandi obiettivi del Piano di gestione dei rischi di inondazione del bacino Senna-Normandia, ovvero: Sviluppare i territori in modo resiliente per ridurne la vulnerabilità; Agire sul rischio per aumentare la sicurezza delle persone e ridurre il costo dei danni; Mobilitare tutti gli attori al servizio della conoscenza e della cultura del rischio.

Periodo: 5/6/2024 – —

Open topic on research and innovation for effective management of EU external borders that promotes fundamental rights and EU values

Unione Europea · EU

Open topic on research and innovation for effective management of EU external borders that promotes fundamental rights and EU values

Periodo: 5/5/2027 – —

Trusted, secure, quality future digital travel credentials

Unione Europea · EU

Trusted, secure, quality future digital travel credentials

Periodo: 5/5/2027 – —

Detection and characterisation of threats or illegal/ smuggled goods in cargo

Unione Europea · EU

Detection and characterisation of threats or illegal/ smuggled goods in cargo

Periodo: 5/5/2027 – —

Open Topic on advanced protective gear optimized for CBRN-E (Chemical, Biological, Radiological, Nuclear, Explosives) environments and new generation of smart protective equipment for disaster responders

Unione Europea · EU

Open Topic on advanced protective gear optimized for CBRN-E (Chemical, Biological, Radiological, Nuclear, Explosives) environments and new generation of smart protective equipment for disaster responders

Periodo: 5/5/2027 – —

Societal resilience, engagement of the younger generations and digital innovation for disaster resilience

Unione Europea · EU

Societal resilience, engagement of the younger generations and digital innovation for disaster resilience

Periodo: 5/5/2027 – —

Enhancing decision support system for disaster crises: leveraging emerging technologies for improved civil preparedness and crisis management

Unione Europea · EU

Enhancing decision support system for disaster crises: leveraging emerging technologies for improved civil preparedness and crisis management

Periodo: 5/5/2027 – —

Enhancing preparedness for large-scale cross-border disasters

Unione Europea · EU

Enhancing preparedness for large-scale cross-border disasters

Periodo: 5/5/2027 – —

Online harms detection and investigation tools using a short development cycle model

Unione Europea · EU

Online harms detection and investigation tools using a short development cycle model

Periodo: 5/5/2027 – —

Community policing in diverse societies in Europe

Unione Europea · EU

Community policing in diverse societies in Europe

Periodo: 5/5/2027 – —

Open topic on enhanced prevention, detection and deterrence of societal issues related to various forms of crime

Unione Europea · EU

Open topic on enhanced prevention, detection and deterrence of societal issues related to various forms of crime

Periodo: 5/5/2027 – —

Open topic on increasing security of citizens against terrorism, including in public spaces

Unione Europea · EU

Open topic on increasing security of citizens against terrorism, including in public spaces

Periodo: 5/5/2027 – —

Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe

Unione Europea · EU

Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe

Periodo: 5/5/2027 – —

Enhancing physical protection of critical infrastructures

Unione Europea · EU

Enhancing physical protection of critical infrastructures

Periodo: 5/5/2027 – —

Impact of malicious use of Open-Source Intelligence on critical infrastructure business continuity

Unione Europea · EU

Impact of malicious use of Open-Source Intelligence on critical infrastructure business continuity

Periodo: 5/5/2027 – —